Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
deals
fda
life sciences
national blog main
national top stories
new york blog main
alirocumab
alnylam pharmaceuticals
amgen
boston
cancer
cancer immunotherapy
center for medicare and medicaid services
clinical trials
companion diagnostic
daniel o'day
evolocumab
foundation medicine
foundationone cdx
foundationone heme
genentech
inclisiran
new york
new york top stories
novartis
osimertinib
pcsk9
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
roche
rucaparib (rubraca)
san francisco blog main
sanofi
the medicines company
What
acquire
2
×
agreed
2
×
billion
big
brings
broad
cash
cholesterol
company
compound
confidence
deal
didn’t
drug
fda
foundation
gain
genentech
medco
medicine
medicines
momentum
morning
new
novartis
panels
pay
pays
picked
poised
profiling
ready
recently
redux
remaining
rest
roche
share
stock
struggled
Language
unset
Current search:
agreed
×
acquire
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine